Literature DB >> 25657290

Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.

Lian-Qun Qiu1, Wi S Lai1, Alyce Bradbury1, Darryl C Zeldin1, Perry J Blackshear2.   

Abstract

TTP is an anti-inflammatory protein that acts by binding to AREs in its target mRNAs, such as Tnf mRNA, and promoting their deadenylation and decay. TNF released from inflammatory cells can then stimulate gene expression in tissue cells, such as fibroblasts. To determine whether TTP could affect the decay of TNF-induced transcripts in fibroblasts, we exposed primary embryonic fibroblasts and stable fibroblast cell lines, derived from WT and TTP KO mice, to TNF. The decay rates of transcripts encoded by several early-response genes, including Cxcl1, Cxcl2, Ier3, Ptgs2, and Lif, were significantly slowed in TTP-deficient fibroblasts after TNF stimulation. These changes were associated with TTP-dependent increases in CXCL1, CXCL2, and IER3 protein levels. The TTP-susceptible transcripts contained multiple, conserved, closely spaced, potential TTP binding sites in their 3'-UTRs. WT TTP, but not a nonbinding TTP zinc finger mutant, bound to RNA probes that were based on the mRNA sequences of Cxcl1, Cxcl2, Ptgs2, and Lif. TTP-promoted decay of transcripts encoding chemokines and other proinflammatory mediators is thus a critical post-transcriptional regulatory mechanism in the response of secondary cells, such as fibroblasts, to TNF released from primary immune cells. © Society for Leukocyte Biology.

Entities:  

Keywords:  AU-rich elements; mRNA decay; mouse embryonic fibroblasts; tumor necrosis factor

Mesh:

Substances:

Year:  2015        PMID: 25657290      PMCID: PMC4370050          DOI: 10.1189/jlb.3A0214-106R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  44 in total

1.  Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction.

Authors:  E Carballo; G S Gilkeson; P J Blackshear
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

Authors:  D Kontoyiannis; M Pasparakis; T T Pizarro; F Cominelli; G Kollias
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

3.  Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Authors:  W S Lai; E Carballo; J R Strum; E A Kennington; R S Phillips; P J Blackshear
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns.

Authors:  Greg Parsonage; Francesco Falciani; Angela Burman; Andrew Filer; Ewan Ross; Margarita Bofill; Stuart Martin; Mike Salmon; Christopher D Buckley
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

5.  Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin.

Authors:  E Carballo; W S Lai; P J Blackshear
Journal:  Science       Date:  1998-08-14       Impact factor: 47.728

Review 6.  Fibroblasts as novel therapeutic targets in chronic inflammation.

Authors:  S J Flavell; T Z Hou; S Lax; A D Filer; M Salmon; C D Buckley
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

7.  Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein.

Authors:  Heping Cao; Jane S Tuttle; Perry J Blackshear
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

8.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

Authors:  G A Taylor; E Carballo; D M Lee; W S Lai; M J Thompson; D D Patel; D I Schenkman; G S Gilkeson; H E Broxmeyer; B F Haynes; P J Blackshear
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

Review 9.  The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.

Authors:  Danielle M Carrick; Wi S Lai; Perry J Blackshear
Journal:  Arthritis Res Ther       Date:  2004-10-08       Impact factor: 5.156

Review 10.  A stromal address code defined by fibroblasts.

Authors:  Greg Parsonage; Andrew D Filer; Oliver Haworth; Gerard B Nash; G Ed Rainger; Michael Salmon; Christopher D Buckley
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

View more
  27 in total

1.  A Knock-In Tristetraprolin (TTP) Zinc Finger Point Mutation in Mice: Comparison with Complete TTP Deficiency.

Authors:  Wi S Lai; Deborah J Stumpo; Lianqun Qiu; Roberta Faccio; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2018-01-29       Impact factor: 4.272

Review 2.  An Ancient Family of RNA-Binding Proteins: Still Important!

Authors:  Melissa L Wells; Lalith Perera; Perry J Blackshear
Journal:  Trends Biochem Sci       Date:  2017-01-14       Impact factor: 13.807

Review 3.  The role of RNA-binding protein tristetraprolin in cancer and immunity.

Authors:  Jian Guo; Huiheng Qu; Ye Chen; Jiazeng Xia
Journal:  Med Oncol       Date:  2017-11-09       Impact factor: 3.064

4.  Importance of the Conserved Carboxyl-Terminal CNOT1 Binding Domain to Tristetraprolin Activity In Vivo.

Authors:  Wi S Lai; Deborah J Stumpo; Melissa L Wells; Artiom Gruzdev; Stephanie N Hicks; Cindo O Nicholson; Zhengfeng Yang; Roberta Faccio; Michael W Webster; Lori A Passmore; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2019-06-13       Impact factor: 4.272

5.  Differences in Tfh Cell Response Between the Graft and Spleen With Chronic Allograft Nephropathy.

Authors:  Jian Shi; Xianlin Xu; Fengbao Luo; Qianqian Shi; Xiaozhou He; Ying Xia
Journal:  Cell Transplant       Date:  2016-08-12       Impact factor: 4.064

6.  Effects of Combined Tristetraprolin/Tumor Necrosis Factor Receptor Deficiency on the Splenic Transcriptome.

Authors:  Sonika Patial; Deborah J Stumpo; W Scott Young; James M Ward; Gordon P Flake; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

Review 7.  Tristetraprolin as a Therapeutic Target in Inflammatory Disease.

Authors:  Sonika Patial; Perry J Blackshear
Journal:  Trends Pharmacol Sci       Date:  2016-08-05       Impact factor: 14.819

8.  Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS.

Authors:  Suharsh Shah; Mahmoud M Mostafa; Andrew McWhae; Suzanne L Traves; Robert Newton
Journal:  J Biol Chem       Date:  2015-11-06       Impact factor: 5.157

9.  Mouse Embryonic Fibroblast Cell Culture and Stimulation.

Authors:  Lian-Qun Qiu; Wi S Lai; Deborah J Stumpo; Perry J Blackshear
Journal:  Bio Protoc       Date:  2016-07-05

10.  Measurement of mRNA Decay in Mouse Embryonic Fibroblasts.

Authors:  Lian-Qun Qiu; Wi S Lai; Deborah J Stumpo; Perry J Blackshear
Journal:  Bio Protoc       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.